Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Allison Toltz
Late Radiation Toxicity in Hodgkin Lymphoma Patients: Proton Therapy's Potential
Journal of Applied Clinical Medical Physics
Instrumentation
Nuclear Medicine
Radiology
Radiation
Imaging
Medicine
Related publications
Proton Versus Photon Deep Inspiration Breath Hold Technique in Patients With Hodgkin Lymphoma and Mediastinal Radiation
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Late Sequelae in Hodgkin Lymphoma Survivors
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cardiac MRI for Detecting Early Cardiac Toxicity After Proton Therapy for Hodgkin Lymphoma
International Journal of Particle Therapy
Nuclear Medicine
Radiology
Molecular Physics,
Imaging
Optics
Atomic
Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Will Evaluating Dose to Coronary Arteries Improve Risk Estimates?
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Modulation of Cardiovascular Toxicity in Hodgkin Lymphoma: Potential Role and Mechanisms of Aerobic Training
Future Cardiology
Molecular Medicine
Cardiovascular Medicine
Cardiology
MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients
PLoS ONE
Multidisciplinary
Comparing Breath Hold and Free Breathing During Intensity-Modulated Radiation Therapy and Proton Therapy in Patients With Mediastinal Hodgkin Lymphoma
International Journal of Particle Therapy
Nuclear Medicine
Radiology
Molecular Physics,
Imaging
Optics
Atomic
Predicted Cardiac and Second Cancer Risks in Hodgkin Lymphoma Patients Treated With Advanced Proton Beam Therapy Compared to Photon Radiation Therapy
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Pulmonary Toxicity in Paediatric Patients With Relapsed or Refractory Hodgkin Lymphoma Receiving Brentuximab Vedotin
British Journal of Haematology
Hematology
